ALS:ALS,

Shao Feng Yu1, Maya Michon1, Anuradha F Lingappa1

  • 1Prosetta Biosciences, Inc., 670 5th St, San Francisco, CA, 94107, USA.

Clinical proteomics
|April 28, 2025
PubMed
概括

组装调节器在治疗肌缩侧面硬化症 (ALS) 中表现有前途. 这些小分子恢复了TDP-43的局部化,并可能纠正血液生物标志物,这表明ALS是一种可治疗的恒常性障碍.